INOVIQ Exosome Diagnostic Solutions

Milestones and catalysts SubB2M and EXO-NET programs moving towards key inflection points For personal use only 19 H2 CY 2023 H1 CY 2024 EXO-NET co-marketing agreement with Promega Results of EXO-OC equivalence study in plasma and serum (n=250) Results SubB2M SPR feasibility study Results SubB2M/CA125 OC analytical validation study Results of SubB2M/CA15-3 BC monitoring study Progress SubB2M partnering TEXO-NET data @ ANZSEV23 meeting Commercial progress SubB2M/CA15-3 LDT Results SubB2M/CA125 OC clinical validation studies NEURO-NET data New EXO-NET collaborations/partnering Progress EXO-OC test collaboration and clinical data INOVIQ

View entire presentation